PoliticalRepoPoliticalRepo

Ireland · Question · written

PQ 671

671. Deputy Aengus Ó Snodaigh asked the Minister for Health the annual cost of treating a patient with Pirfenidone when they are suffering with idiopathic pulmonary fibrosis; the number of persons who suffer from this condition within this jurisdiction; the method by which the National Centre for Pharmacoeconomics assess if a treatment is cost effective; and if he will make a statement on the matter. [22755/13]

askedIreland· Dáil Éireann· EN

Introduced

14 May 2013

Last action

14 May 2013 · Medicinal Products Supply

Status

written

Sponsors

Ó Snodaigh, Aengus.

Subjects

Discovery layer

Source updated

14 May 2013

Summary

671. Deputy Aengus Ó Snodaigh asked the Minister for Health the annual cost of treating a patient with Pirfenidone when they are suffering with idiopathic pulmonary fibrosis; the number of persons who suffer from this condition within this jurisdiction; the method by which the National Centre for Pharmacoeconomics assess if a treatment is cost effective; and if he will make a statement on the matter. [22755/13]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 14 May 2013

    Medicinal Products Supply

    671. Deputy Aengus Ó Snodaigh asked the Minister for Health the annual cost of treating a patient with Pirfenidone when they are suffering with idiopathic pulmonary fibrosis; the number of persons who suffer from this condition within this jurisdiction; the method by which the National Centre for Pharmacoeconomics assess if a treatment is cost effective; and if he will make a statement on the matter. [22755/13]

    Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Medicinal Products Supply

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.